New study evaluated the safety and feasibility of adult retinal stem cell-derived RPE transplants in non-human primates.

‘RPE patches transplanted into the monkey's eye stably integrated for at least three months with no serious side effects.’
Read More..

To restore this population of cells, researchers extracted retinal stem cells from donated cadaver adult eyes, grew them into RPE cells and transplanted them into the eyes of monkeys. These unique cells have the potential to serve as an unlimited resource of human RPE, with the possibility of donor compatibility matching.Read More..





The study is the first time the safety and feasibility of adult retinal stem cell-derived RPE transplants in non-human primates was assessed. Researchers found that RPE patches transplanted into the monkey's eye stably integrated for at least three months with no serious side effects.
What is more, the stem cell-derived RPE partially took over the function of the monkey RPE and was able to support normal photoreceptor function. Importantly, these cells did not cause retinal scarring.
Altogether, this demonstrates the feasibility of using adult retinal stem cell-derived RPE transplants to replace defective RPE as a possible treatment for macular degeneration. However, further experiments need to be conducted.
This includes evidence to demonstrate adult retinal stem cell-derived RPE can restore vision in diseased non-human primate models, and eventually in regulatory human clinical trials.
Advertisement